(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate

Concentración máxima permitida

(a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE

Marco regulatorio

Reglamento (CE) 1223/2009 — Anexo III, ref. 376

Última modificación reflejada en la BD: 4 de abril de 2024

Condiciones de uso

From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 May 2027 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.

Tipo de producto: (a) Body lotion (b) other leave-on and rinse-off products

Advertencias de etiquetado

For any cosmetic product containing Retinol, Retinyl Acetate or Retinyl Palmitate the following, labelling is obligatory: ‘Contains Vitamin A. Consider your daily intake before use’.